跳至主要内容
临床试验/NCT05423613
NCT05423613进行中(未招募)不适用

Randomized Controlled Evaluator-blinded Trial of Microneedling for the Treatment of Hypertrophic Scars of Adult Burn Survivors and Patients With Severe Skin Disorders

Centre hospitalier de l'Université de Montréal (CHUM)1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2021年1月22日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
36
试验地点
1
主要终点
Skin Erythema Changes

研究概览

简要总结

Approximately 33 to 91% of severe burn victims will develop hypertrophic scars. Hypertrophic scars are defined as erythematous (red), raised and rigid scars that can cause pain and itching, among other things. They cause psychological distress and affect the quality of life of burn victims. Microneedling is a technique that uses an electrical device to create hundreds of microchannels that penetrate the skin layers. This study is interested in determining the effectiveness of microneedling in improving the pliability, thickness and erythema of hypertrophic scars. Each scar will receive up to 5 ACS-pen treatments followed by the application of cortisone (triamcinolone acetonide). Knowing that microneedling increases the absorption of products applied to the skin by about 80%, it is logical to think that creating these channels to the dermis and applying cortisone afterwards would have a beneficial effect on the hypertrophic scars of these patients.

详细描述

Patients will receive microneedling once every six weeks for a maximum of five treatments

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
16 Years 至 100 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Any gender or race
  • 16 years of age or older
  • Have at least 2 HSc that meet the clinical criteria for HSc
  • Provide written informed consent.

排除标准

  • Patients with keloid scars
  • Mature scar site
  • A psychiatric condition or cognitive impairment that interferes with their ability to follow the treatment protocol
  • Dermatological conditions (i.e. psoriasis, eczema, etc.) in the area of the evaluation site
  • An allergy to ultrasound gel
  • On anticoagulant medications
  • Inability to understand English or French.

研究组 & 干预措施

Microneedling treated scar

Experimental

Microneedling

干预措施: Microneedling (Procedure)

Control scar

No Intervention

No intervention, standard of care

结局指标

主要结局

Skin Erythema Changes

时间窗: Baseline, before treatments #3, #4 and #5, post 6 weeks and 12 weeks

Erythema index measure by Mexameter, values from 0 to 999. The erythema values are individual for each person and depend strongly on the ethnic group. The measurements are generally used to determine changes before and after a treatment.

Cutometer Skin Elasticity Changes

时间窗: Baseline, before treatments #3, #4 and #5, post 6 weeks and 12 weeks

Skin elasticity measures (r0- Cutometer), mm

Skin Thickness Changes

时间窗: Baseline, before treatments #3, #4 and #5, post 6 weeks and 12 weeks

Ultrasound skin measures, mm

次要结局

  • Patient reported effectiveness of intervention(Baseline, 12 weeks post intervention)

研究者

发起方
Centre hospitalier de l'Université de Montréal (CHUM)
申办方类型
Other
责任方
Principal Investigator
主要研究者

Bernadette Nedelec

Full professor, McGill University

Centre hospitalier de l'Université de Montréal (CHUM)

研究点 (1)

Loading locations...

相似试验